NeOnc Technologies Holdings, Inc. (NTHI)
3.19
-0.01
(-0.31%)
USD |
NASDAQ |
Nov 06, 10:26
NeOnc Technologies Holdings Net Income (Quarterly) : -14.24M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -14.24M |
| March 31, 2026 | -8.820M |
| December 31, 2025 | -15.52M |
| September 30, 2025 | -8.616M |
| June 30, 2025 | -5.680M |
| March 31, 2025 | -32.33M |
| December 31, 2024 | -2.253M |
| Date | Value |
|---|---|
| September 30, 2024 | -2.184M |
| March 31, 2024 | -2.939M |
| December 31, 2023 | -6.155M |
| September 30, 2023 | -3.594M |
| December 31, 2022 | -1.066M |
| September 30, 2022 | -0.7543M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | -3.164M |
| CNBX Pharmaceuticals, Inc. | -0.1542M |
| Arvinas, Inc. | -53.90M |
| Fulcrum Therapeutics, Inc. | -26.18M |
| Definium Therapeutics, Inc. | -158.99M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 14.24M |
| EPS Diluted (Quarterly) | -0.5774 |
| Enterprise Value | 77.89M |
| Earnings Yield | -66.47% |
| Normalized Earnings Yield | -65.67 |